Veery Capital’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
LMFP
ATO
HCM
AAMU
FWCM
Veery Capital's ABBV Position: Q2 2026 in Review
Veery Capital opened a new position in AbbVie (ABBV) in Q2 2026: 891 shares worth $224K. The stake represents 0.06% of the portfolio and ranks #92 among its holdings. This is a return to the name: Veery Capital previously reported a position in ABBV as recently as Q4 2025.
Veery Capital first reported a position in ABBV in Q4 2021 and has held it in 15 quarters since. The position peaked at $291K in Q3 2024. 1,265 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Veery Capital held 891 shares of AbbVie worth $224K as of Q2 2026.
- AbbVie was a new Veery Capital position in Q2 2026.
- AbbVie made up 0.06% of Veery Capital's portfolio in Q2 2026, its #92 holding.
- Veery Capital first reported a position in AbbVie in Q4 2021 and has held it in 15 quarters since.
- Veery Capital's AbbVie position peaked at $291K in Q3 2024.
- 1,265 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Veery Capital's 13F filing for Q2 2026, filed 9 Jul 2026.